首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists
【24h】

Structure-Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists

机译:高选择性,长效,基于肽的胆囊蛋白1受体激动剂的结构 - 活性关系与表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A group of peptide-based, long-acting, stable, highly selective cholecystokinin 1 receptor (CCK-1R) agonists with the potential to treat obesity has been identified and characterized, based on systematic investigation of synthetic CCK-8 analogues with N-terminal linkage to fatty acids. Sulfated Tyr in such compounds was stable in neutral buffer. CCK-1R selectivity was achieved mostly by introducing D-N-methyl-Asp instead of Asp at the penultimate position of CCK-8. Our compound 9 (NN9056) showed similar in vitro CCK-1R potency and CCK-1R affinity as CCK-8, very high selectivity for CCK-1R over the cholecystokinin 2 receptor (CCK-2R), strong reduction of food intake in lean pigs for up to 48 h after one subcutaneous injection without adverse effects, a plasma half-life of 113 h in minipigs after intravenous injection, and acceptable chemical stability in a neutral liquid formulation. In addition, we found a highly selective CCK-2R agonist by replacing Gly in a CCK-8 derivative with Glu.
机译:一组基于肽的,长效,稳定的高度选择性胆囊蛋白1受体(CCK-1R)的激动剂,其具有治疗肥胖症的潜力,并基于具有N末端的合成CCK-8类似物的系统研究 与脂肪酸的联系。 在这些化合物中的硫酸化Tyr在中性缓冲液中稳定。 通过在CCK-8的倒数第二位置引入D-N-甲基-AP而不是ASP来实现CCK-1R选择性。 我们的化合物9(NN9056)显示出与CCK-8的体外CCK-1R效力和CCK-1R亲和力相似,CCK-1R在胆囊蛋白2受体(CCK-2R)上具有非常高的CCK-1R的选择性,瘦猪中的食物摄入量强烈减少 在一次皮下注射后长达48小时,没有不良反应,在静脉注射液中的微量化物中的血浆半衰期为113小时,并在中性液体制剂中获得可接受的化学稳定性。 此外,我们通过Glu替换CCK-8衍生物中的含量,找到了一种高度选择性的CCK-2R激动剂。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2019年第3期|共13页
  • 作者单位

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Drug Discovery Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Drug Discovery Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Res Technol Novo Nordisk Pk DK-2760 Malov Denmark;

    Novo Nordisk AS Global Drug Discovery Novo Nordisk Pk DK-2760 Malov Denmark;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号